Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
Acne Vulgaris
Interventions
DRUG

Adapalene/ BPO gel with Lymecycline capsules

Gel: Topical to the face, once daily in the evening Capsule: 1 capsule once daily in the morning

DRUG

Adapalene/ BPO vehicle gel with Lymecycline capsules

Gel: Topical to the face, once daily in the evening Capsule: 1 capsule once daily in the morning

Trial Locations (28)

Unknown

Galderma Investigator site, Canberra

Galderma Investigator site, Kogarah

Galderma Investigator site, Melbourne

Galderma Investigator site, Sydney

Galderma Investigator site, Brussels

Galderma Investigator site, Ghent

Galderma Investigator site, Leuven

Galderma Investigator site, Belo Horizonte

Galderma Investigator site, São Paulo

Galderma Investigator site, Bordeaux

Galderma Investigator site, Cannes

Galderma Investigator site, Martigues

Galderma Investigator site, Nantes

Galderma Investigator site, Pantin

Galderma Investigator site, Pierre-Bénite

Galderma Investigator site, Cuxhaven

Galderma Investigator site, Darmstadt

Galderma Investigator site, Frankfurt

Galderma Investigator site, Catania

Galderma Investigator site, Ferrara

Galderma Investigator site, Mexico City

Galderma Investigator site, Monterrey

Galderma Investigator site, Tlalnepantla

Galderma Investigator site, Zapopan

Galderma Investigator site, Lodz

Galderma Investigator site, Eskilstuna

Galderma Investigator site, Farsta

Galderma Investigator site, Hägersten

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY

NCT01014689 - Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris | Biotech Hunter | Biotech Hunter